文献速递艾滋病与性传播感染病毒性肝炎

HIV感染与脂肪变性对女性肝纤维化发生风险的预测作用

Predictors of Incident Hepatic Fibrosis and Steatotic Liver Disease-Associated Fibrosis Among Women with and without HIV.
PubMed 文献 · J Infect Dis · 2026-10-31

本研究基于WIHS/MACS-WIHS联合队列,纳入1036名无病毒性肝炎且无重度饮酒的女性(709名HIV感染者,327名未感染者),分析肝纤维化发生的预测因素。平均随访3.5年,19%发生纤维化;HIV感染(IRR 1.72)和较高CAP值(每10 dB/m,IRR 1.04)与纤维化相关,且CAP与纤维化的关联在HIV感染者中减弱。无脂肪变性的纤维化在HIV感染者中占28%,提示HIV特异性肝损伤途径。

要点

  • HIV感染是无病毒性肝炎女性发生肝纤维化的独立预测因素。
  • 脂肪变性(CAP)对纤维化的预测作用在HIV感染者中较弱。
  • HIV感染者中无脂肪变性的纤维化常见,需关注非脂肪性肝损伤。

核心结论

  • HIV感染预测肝纤维化发生,而脂肪变性在HIV感染者中是较弱的预测因素。
  • 无脂肪变性的纤维化常见,提示存在不同的纤维化表型和潜在HIV特异性肝损伤通路。

研究设计与样本

  • 纳入WIHS(现为MACS/WIHS联合队列)中2013-2020年接受VCTE且至少两次检查的女性,排除病毒性肝炎、重度饮酒或基线纤维化者。
  • 共1036名女性(709名HIV感染者,327名未感染者),中位年龄49岁,中位BMI 32 kg/m2,平均随访3.5年。
  • 采用Poisson回归估计纤维化(肝硬度≥7.1 kPa)的发生率比(IRR),模型包含时间更新协变量并检验HIV与CAP的交互作用。

主要发现

  • 随访期间19%发生肝纤维化。
  • 多变量调整模型中,HIV感染与纤维化相关(IRR 1.72,95% CI 1.12-2.65)。
  • 较高CAP(每10 dB/m)与纤维化相关(IRR 1.04,95% CI 1.00-1.08)。
  • CAP与纤维化的关联因HIV状态而异(交互作用p=0.02),在HIV感染者中减弱。
  • 无脂肪变性的纤维化在HIV感染者新发纤维化中占28%,在有既往AIDS病史者中更常见。

关键数值与推荐

  • 纤维化定义为肝硬度≥7.1 kPa。
  • 脂肪变性通过受控衰减参数(CAP)评估。
  • HIV感染IRR 1.72(95% CI 1.12-2.65);CAP每10 dB/m的IRR 1.04(95% CI 1.00-1.08)。
  • HIV与CAP交互作用p=0.02。

临床怎么用

  • 对HIV感染者应定期评估肝纤维化,即使无脂肪变性也需警惕。
  • CAP评估脂肪变性在HIV感染者中对纤维化的预测价值有限,需结合其他指标。
  • 有既往AIDS病史的HIV感染者可能是无脂肪变性纤维化的高危人群。

局限性

  • 研究人群为女性,结论外推至男性需谨慎。
  • 排除病毒性肝炎和重度饮酒者,结果不适用于这些人群。
  • 观察性研究,无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Liver fibrosis is an important cause of non-AIDS morbidity among women with HIV (WWH), but predictors of incident fibrosis in the absence of viral hepatitis are not well defined. METHODS: We included women with and without HIV enrolled in the Women's Interagency HIV Study (WIHS), now part of the MACS/WIHS Combined Cohort Study, who underwent vibration-controlled transient elastography (VCTE) between 2013 and 2020 as part of the Liver Disease and Reproductive Aging (LIVRA) Study and had at least two VCTE exams. Participants with viral hepatitis, heavy alcohol use, or baseline fibrosis were excluded. Poisson regression estimated incidence rate ratios (IRRs) for incident fibrosis, defined as liver stiffness ≥7.1 kPa. Models included time-updated covariates and tested interactions between HIV and steatosis measured by controlled attenuation parameter (CAP). RESULTS: Among 1,036 women (709 WWH, 327 without HIV), median age was 49 years and median BMI 32 kg/m2. Over a mean follow-up of 3.5 years, 19% developed incident fibrosis. HIV infection (IRR 1.72, 95% CI 1.12-2.65) and higher CAP (per 10 dB/m; IRR 1.04, 95% CI 1.00-1.08) were associated with fibrosis in multivariable adjusted models. The association between CAP and fibrosis differed by HIV status (interaction p = 0.02) and was attenuated among WWH. Fibrosis without steatosis accounted for 28% of new fibrosis in WWH and was more common in those with prior AIDS. CONCLUSIONS: HIV infection predicted incident hepatic fibrosis, while steatosis was a weaker predictor in WWH. Fibrosis without steatosis was common, suggesting distinct fibrosis phenotypes and potential HIV-specific pathways of liver injury.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Duarte MJ, Tien PC, Ma Y, et al. Predictors of Incident Hepatic Fibrosis and Steatotic Liver Disease-Associated Fibrosis Among Women with and without HIV. J Infect Dis. 2026. PMID: 42965316. doi:10.1093/infdis/jiag532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。